162 related articles for article (PubMed ID: 38296737)
1. Concurrent Use of Statins in Patients Undergoing Curative Intent Treatment for Triple Negative Breast Cancer: A Systematic Review and Meta-Analysis.
McKechnie T; Brown Z; Lovrics O; Yang S; Kazi T; Eskicioglu C; Parvez E
Clin Breast Cancer; 2024 Apr; 24(3):e103-e115. PubMed ID: 38296737
[TBL] [Abstract][Full Text] [Related]
2. Concurrent use of statins and neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis.
McKechnie T; Talwar G; Lee Y; Levine O; Eskicioglu C
Int J Colorectal Dis; 2021 Dec; 36(12):2715-2727. PubMed ID: 34498133
[TBL] [Abstract][Full Text] [Related]
3. Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer.
Hoon SN; Lau PK; White AM; Bulsara MK; Banks PD; Redfern AD
Cochrane Database Syst Rev; 2021 May; 5(5):CD011220. PubMed ID: 34037241
[TBL] [Abstract][Full Text] [Related]
4. Statins for Smith-Lemli-Opitz syndrome.
Ballout RA; Livinski A; Fu YP; Steiner RD; Remaley AT
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013521. PubMed ID: 36373961
[TBL] [Abstract][Full Text] [Related]
5. Association of statin use with clinical outcomes in patients with triple-negative breast cancer.
Nowakowska MK; Lei X; Thompson MT; Shaitelman SF; Wehner MR; Woodward WA; Giordano SH; Nead KT
Cancer; 2021 Nov; 127(22):4142-4150. PubMed ID: 34342892
[TBL] [Abstract][Full Text] [Related]
6. Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells.
O'Grady S; Crown J; Duffy MJ
Med Oncol; 2022 Jul; 39(10):142. PubMed ID: 35834073
[TBL] [Abstract][Full Text] [Related]
7. Effects of Statins on Renal Outcome in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis.
Sanguankeo A; Upala S; Cheungpasitporn W; Ungprasert P; Knight EL
PLoS One; 2015; 10(7):e0132970. PubMed ID: 26151753
[TBL] [Abstract][Full Text] [Related]
8. Statin Use and Survival Among Men Receiving Androgen-Ablative Therapies for Advanced Prostate Cancer: A Systematic Review and Meta-analysis.
Jayalath VH; Clark R; Lajkosz K; Fazelzad R; Fleshner NE; Klotz LH; Hamilton RJ
JAMA Netw Open; 2022 Nov; 5(11):e2242676. PubMed ID: 36449294
[TBL] [Abstract][Full Text] [Related]
9. HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass.
Lewicki M; Ng I; Schneider AG
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010480. PubMed ID: 25758322
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
[TBL] [Abstract][Full Text] [Related]
12. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis.
Gao G; Wang Z; Qu X; Zhang Z
BMC Cancer; 2020 Mar; 20(1):179. PubMed ID: 32131780
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Jamialahmadi T; Baratzadeh F; Reiner Ž; Simental-Mendía LE; Xu S; Susekov AV; Santos RD; Sahebkar A
Mediators Inflamm; 2021; 2021():9661752. PubMed ID: 34526854
[TBL] [Abstract][Full Text] [Related]
15. PARP (Poly ADP-Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer.
Taylor AM; Chan DLH; Tio M; Patil SM; Traina TA; Robson ME; Khasraw M
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011395. PubMed ID: 33886122
[TBL] [Abstract][Full Text] [Related]
16. Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.
Sanders RD; Nicholson A; Lewis SR; Smith AF; Alderson P
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD009971. PubMed ID: 23824754
[TBL] [Abstract][Full Text] [Related]
17. Effects of statin exposure and lung cancer survival: A meta-analysis of observational studies.
Chen Y; Li X; Zhang R; Xia Y; Shao Z; Mei Z
Pharmacol Res; 2019 Mar; 141():357-365. PubMed ID: 30641276
[TBL] [Abstract][Full Text] [Related]
18. Use of Statins to Augment Progenitor Cell Function in Preclinical and Clinical Studies of Regenerative Therapy: a Systematic Review.
Park A; Barrera-Ramirez J; Ranasinghe I; Pilon S; Sy R; Fergusson D; Allan DS
Stem Cell Rev Rep; 2016 Jun; 12(3):327-39. PubMed ID: 26873165
[TBL] [Abstract][Full Text] [Related]
19. Impact of statin on renal cell carcinoma patients undergoing nephrectomy. Does it affect cancer progression and improves survival? A Systematic Review and Meta-Analysis.
Adli G; Yogiswara N; Gde Tirta Yoga Yatindra IB; Putra RM; Djatisoesanto W
Arch Ital Urol Androl; 2023 Oct; 95(3):11672. PubMed ID: 37791546
[TBL] [Abstract][Full Text] [Related]
20. Impact of platinum-based chemotherapy on the prognosis of early triple-negative breast cancer: a systematic review and meta-analysis.
Zhao F; Shen G; Dong Q; Xin Y; Huo X; Wang M; Liu Z; Zhao Y; Ren D; Xie Q; Liu Z; Li Z; Gao L; Du F; Zhao J
Clin Exp Med; 2023 Oct; 23(6):2025-2040. PubMed ID: 36422737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
